BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/12/2015 7:10:00 PM | Browse: 1302 | Download: 1743
Publication Name World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID 19668
Country/Territory Australia
Received
2015-05-16 14:45
Peer-Review Started
2015-05-20 08:54
To Make the First Decision
2015-07-27 16:08
Return for Revision
2015-08-10 17:37
Revised
2015-08-24 12:30
Second Decision
2015-09-28 14:32
Accepted by Journal Editor-in-Chief
2015-09-29 10:47
Accepted by Company Editor-in-Chief
2015-10-13 17:10
Articles in Press
2015-10-13 17:10
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-10-23 15:49
Publish the Manuscript Online
2015-11-12 18:51
ISSN 2150-5349 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
Manuscript Source Invited Manuscript
All Author List Bei Ye and Daniel R van Langenberg
Funding Agency and Grant Number
Corresponding Author Dr. Daniel R van Langenberg, Department of Gastroenterology, Eastern Health, Arnold Street, Box Hill, Victoria 3128, Australia. daniel.van-langenberg@monash.edu
Key Words Colitis; Ulcerative; Drug delivery systems; Mesalamine; Sulfasalazine; Therapeutic equivalency
Core Tip Various formulations of oral mesalazine are available for management of mild to moderate ulcerative colitis. Selection of the most appropriate formulation requires tailoring of the therapy to the individual and must incorporate factors such as disease distribution, efficacy, side effect profile, pill burden, patient preference and health economics.
Publish Date 2015-11-12 18:51
Citation Ye B, van Langenberg DR. Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal? World J Gastrointest Pharmacol Ther 2015; 6(4): 137-144
URL http://www.wjgnet.com/2150-5349/full/v6/i4/137.htm
DOI http://dx.doi.org/10.4292/wjgpt.v6.i4.137
Full Article (PDF) WJGPT-6-137.pdf
Full Article (Word) WJGPT-6-137.doc
Manuscript File 19668-Review.docx
Answering Reviewers 19668-Answering reviewers.pdf
Audio Core Tip 19668-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 19668-Conflict-of-interest statement.pdf
Copyright License Agreement 19668-Copyright assignment.pdf
Peer-review Report 19668-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 19668-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 19668-Scientific misconduct check.pdf
Scientific Editor Work List 19668-Scientific editor work list.pdf